Astellas Pharma Inc (OP: ALPMF )
16.64 -0.30 (-1.80%) Streaming Delayed Price Updated: 2:23 PM EDT, May 26, 2023 Add to My Watchlist
Headline News about Astellas Pharma Inc
Astellas' Menopause Drug Under FDA Review
August 18, 2022
Sutro Biopharma Stock Surges On Cancer Treatment Pact
June 28, 2022
FibroGen Shares Are Trading Lower As FDA Shoots Down Roxadustat Application, Asks For Additional Trial
August 11, 2021
The FDA has issued a complete response letter regarding the marketing application for FibroGen Inc's (NASDAQ: FGEN) roxadustat for anemia of chronic kidney disease...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following